- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04427982
Dance and Diabetes/Prediabetes Self-Management
October 26, 2021 updated by: Wake Forest University Health Sciences
Dance as an Intervention to Improve Diabetes and Prediabetes Self-Management
The Dance for Diabetes program was designed as a community service project for the North Carolina Albert Schweitzer Fellowship.
The purpose of this research is to evaluate the effectiveness of the project and its impact on participants.
This study will assess whether a group dance workshop along with diabetes education can help people with diabetes and prediabetes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a pilot study that will be testing whether or not a group dance workshop is useful and effective.
If it is, the study team will refine the workshop model and do additional dance classes in the future.
This research study will involve attending a dance workshop once a week for 2 months using an online, video-conferencing computer application.
Participants will also receive information about exercise and how to manage their diabetes.
Participants will receive a phone call every week during the 2 months to assess their experience.
Study participants will also be asked to complete surveys at the beginning and end of the 2-month session, as well as 1 month and 2 months after the classes end.
Study Type
Interventional
Enrollment (Actual)
25
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest Baptist Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- adults proficient in English with diabetes or prediabetes
- subjects who have an established healthcare provider
Exclusion Criteria:
- known cardiovascular disease (acute coronary syndrome, stable or unstable angina, coronary or other arterial revascularization, stroke, transient ischemic attack, and peripheral arterial disease) for the last 6 months
- unwilling or unable to partake in light to moderate level of dance physical activity for 1 hour because of physical impairment (e.g. wheelchair, amputation)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental Group
All participants will attend a 2-month weekly light-to-moderate intensity dance workshop followed by a brief diabetes education and discussion session.
|
Participants will attend a 2-month weekly light-to-moderate intensity dance workshop.
The dance classes will be followed by a brief diabetes education and discussion session.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
National Health and Nutrition Examination Survey Physical Activity and Physical Fitness Questionnaire (NHANES 2019-2020 PAQ)--Activity Confirmation
Time Frame: baseline
|
Percentage of subjects who confirm that they are physically active in questionnaire
|
baseline
|
NHANES 2019-2020 PAQ--Days Active
Time Frame: baseline
|
Average number of days subjects report being active
|
baseline
|
NHANES 2019-2020 PAQ--minutes active
Time Frame: baseline
|
Average number of minutes (10-60) per day that participants engage in activity
|
baseline
|
NHANES 2019-2020 PAQ--Activity Confirmation
Time Frame: 4 weeks post intervention completion
|
Percentage of subjects who confirm that they are physically active in questionnaire
|
4 weeks post intervention completion
|
NHANES 2019-2020 PAQ--Days Active
Time Frame: 4 weeks post intervention completion
|
Average number of days subjects report being active
|
4 weeks post intervention completion
|
NHANES 2019-2020 PAQ--minutes active
Time Frame: 4 weeks post intervention completion
|
Average number of minutes (10-60) per day that participants engage in activity
|
4 weeks post intervention completion
|
NHANES 2019-2020 PAQ--Activity Confirmation
Time Frame: 8 weeks post baseline
|
Percentage of subjects who confirm that they are physically active in questionnaire
|
8 weeks post baseline
|
NHANES 2019-2020 PAQ--Days Active
Time Frame: 8 weeks post baseline
|
Average number of days subjects report being active
|
8 weeks post baseline
|
NHANES 2019-2020 PAQ--minutes active
Time Frame: 8 weeks post baseline
|
Average number of minutes (10-60) per day that participants engage in activity
|
8 weeks post baseline
|
NHANES 2019-2020 PAQ--Activity Confirmation
Time Frame: 8 weeks post intervention completion
|
Percentage of subjects who confirm that they are physically active in questionnaire
|
8 weeks post intervention completion
|
NHANES 2019-2020 PAQ--Days Active
Time Frame: 8 weeks post intervention completion
|
Average number of days subjects report being active
|
8 weeks post intervention completion
|
NHANES 2019-2020 PAQ--minutes active
Time Frame: 8 weeks post intervention completion
|
Average number of minutes (10-60) per day that participants engage in activity
|
8 weeks post intervention completion
|
Diabetes Empowerment Scale (DES) score
Time Frame: baseline
|
Score ranges from 1 to 5, with 1 denoting a worse outcome.
|
baseline
|
DES Score
Time Frame: 4 weeks post intervention completion
|
This questionnaire is given to determine if there were any changes in participants' activity level 4 weeks post intervention.
Score ranges from 1 to 5, with 1 denoting a worse outcome.
|
4 weeks post intervention completion
|
DES score
Time Frame: 8 weeks post baseline
|
This questionnaire is given 8 weeks post baseline in order to determine any improvements made during the intervention.
Score ranges from 1 to 5, with 1 denoting a worse outcome.
|
8 weeks post baseline
|
DES Score
Time Frame: 8 weeks post intervention completion
|
This questionnaire is given to determine if there were any changes in participants' activity level 8 weeks post intervention.
Score ranges from 1 to 5, with 1 denoting a worse outcome.
|
8 weeks post intervention completion
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight
Time Frame: 8 weeks post intervention completion
|
measured in kilograms
|
8 weeks post intervention completion
|
Body Mass Index (BMI)
Time Frame: 8 weeks post intervention completion
|
Weight in kilograms divided by the square of height in meters.
A high BMI can be an indicator of high body fatness.
|
8 weeks post intervention completion
|
Glycated Hemoglobin (A1c)
Time Frame: 8 weeks post intervention completion
|
The A1c test is a blood test that provides information about average levels of blood glucose over the past 3 months.
The A1c test can be used to diagnose type 2 diabetes and prediabetes.
The A1c test result is reported as a percentage.
The higher the percentage, the higher the blood glucose levels have been.
A normal A1c level is below 5.7 percent
|
8 weeks post intervention completion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Julienne Kirk, PharmD, Wake Forest University Health Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 3, 2020
Primary Completion (Actual)
May 3, 2021
Study Completion (Actual)
May 3, 2021
Study Registration Dates
First Submitted
June 8, 2020
First Submitted That Met QC Criteria
June 10, 2020
First Posted (Actual)
June 11, 2020
Study Record Updates
Last Update Posted (Actual)
November 3, 2021
Last Update Submitted That Met QC Criteria
October 26, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00065214
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
All of the individual participant data collected during the trial will be available after deidentification.
IPD Sharing Time Frame
All data will be available immediately following publication without end date.
IPD Sharing Access Criteria
Information will be available to anyone who wishes to access the data for any purpose.
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
- Clinical Study Report (CSR)
- Analytic Code
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
Garvan Institute of Medical ResearchWeizmann Institute of ScienceActive, not recruitingType 2 Diabetes Mellitus | Pre DiabetesAustralia
-
Oregon State UniversitySanofiCompletedType I or Type II Diabetes (Excludes Gestational Diabetes)
-
Taichung Veterans General HospitalNational Health Research Institutes, TaiwanRecruitingDiabetes Complications | Type 2 Diabetes | Maturity-Onset Diabetes of the Young (MODY)Taiwan
-
University of RoehamptonRecruitingType2 Diabetes Mellitus | Pre DiabetesUnited Kingdom
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
Clinical Trials on dance
-
University of Illinois at ChicagoNational Institute on Aging (NIA)Active, not recruitingMild Cognitive Impairment | Older Adults | Neurological InjuryUnited States
-
Universidade Federal de Sao CarlosCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Universidade...UnknownFamily CaregiverBrazil
-
Ospedale Generale Di Zona Moriggia-PelasciniUnknown
-
National Taiwan University HospitalCompleted
-
University of Illinois at ChicagoSuspendedStrokeUnited States
-
Ohio State UniversityCompletedMultiple SclerosisUnited States
-
Universiti Putra MalaysiaRecruitingMental Health Issue | Physical IllnessChina
-
National and Kapodistrian University of AthensActive, not recruiting
-
Centre Hospitalier Universitaire de LiegeKinésiphiliaRecruiting